Results 11 to 20 of about 2,478,440 (395)

The Surgical Management of Lung Neuroendocrine Neoplasms [PDF]

open access: yesCancers, 2023
This review summarizes key recent developments relevant to the surgical management of lung neuroendocrine neoplasms (L-NENs), including typical and atypical carcinoids, large cell neuroendocrine carcinoma, and small cell lung carcinoma. This review includes recent insights into the classification, clinical presentation, diagnostic workup, treatment ...
Patrick Soldath   +1 more
openaire   +4 more sources

mTOR in Lung Neoplasms

open access: yesPathology & Oncology Research, 2020
With the discovery of rapamycin 45 years ago, studies in the mechanistic target of rapamycin (mTOR) field started 2 decades before the identification of the mTOR kinase. Over the years, studies revealed that the mTOR signaling is a master regulator of homeostasis and integrates a variety of environmental signals to regulate cell growth, proliferation ...
Anna Sebestyén   +2 more
openaire   +4 more sources

Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study

open access: yesJournal of Orthopaedic Surgery and Research, 2020
Background Large population-based studies of risk factor for lung metastases at the presentation with primary osseous neoplasms are lacking and necessary.
Lin Xie   +4 more
doaj   +2 more sources

A molecular map of lung neuroendocrine neoplasms [PDF]

open access: yesGigaScience, 2020
Abstract Background Lung neuroendocrine neoplasms (LNENs) are rare solid cancers, with most genomic studies including a limited number of samples. Recently, generating the first multi-omic dataset for atypical pulmonary carcinoids and the first methylation dataset for large-cell neuroendocrine ...
Aurélie A G Gabriel   +9 more
openaire   +4 more sources

Dual targeting PET tracer [68Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study. [PDF]

open access: yesTheranostics, 2023
Rationale: Early discovery, accurate diagnosis, and staging of lung cancer is essential for patients to receive appropriate treatment. PET/CT has become increasingly recognized as a valuable imaging modality for these patients, but there remains room for
Wang R   +10 more
europepmc   +2 more sources

Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms. [PDF]

open access: yesOncotarget, 2016
Tobacco smoke is a well-established lung cancer carcinogen. We hypothesize that epigenetic processes underlie carcinogenesis. The objective of this study is to examine the effects of smoke exposure on DNA methylation to search for novel susceptibility ...
Freeman JR, Chu S, Hsu T, Huang YT.
europepmc   +2 more sources

Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA. [PDF]

open access: yesNat Commun, 2015
Lungs resected for adenocarcinomas often harbour minute discrete foci of cytologically atypical pneumocyte proliferations designated as atypical adenomatous hyperplasia (AAH).
Izumchenko E   +12 more
europepmc   +2 more sources

Lung autotransplantation for treating bronchus neoplasms

open access: goldChinese Medical Journal, 2007
Yijun Tang   +3 more
openalex   +4 more sources

Giant inflammatory pseudotumor of the lung: a case report [PDF]

open access: yesFolia Medica, 2023
The inflammatory myofibroblastic tumor, which was first described in 1939, is a rare neoplasm that accounts for 0.04%–0.7% of all lung neoplasms.
Alexey Shabunin   +4 more
doaj   +3 more sources

Lung neuroendocrine neoplasms: recent progress and persistent challenges

open access: yesModern Pathology, 2021
This review summarizes key recent developments relevant to the pathologic diagnosis of lung neuroendocrine neoplasms, including carcinoids, small cell lung carcinoma (SCLC), and large cell neuroendocrine carcinoma (LCNEC).
N. Rekhtman
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy